Holen Sie sich die Stockscreener-App
21.72
2.84%
0.60
Quantum Biopharma Ltd Aktie (QNTM) Neueste Nachrichten
Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress - Newsfile
Keg, LQWD, Quantum at 52-Week Highs on News - Baystreet.ca
Quantum BioPharma Ltd. Initiates Groundbreaking MS Study with Massachusetts General Hospital - citybuzz -
Quantum BioPharma Says First Person With Multiple Sclerosis Scanned in Joint Study With Hospital - MarketScreener
Quantum BioPharma and MGH Launch MS Study with Novel Imaging Technique - TipRanks
Quantum BioPharma (QNTM) Initiates MS Imaging Study with Massachusetts General | QNTM Stock News - GuruFocus
Quantum BioPharma Announces First Person with Multiple - GlobeNewswire
Revolutionary MS Brain Imaging Study Launches at Harvard's MGH: First Patient Milestone Achieved - Stock Titan
Quantum BioPharma Ltd. Announces Special Dividend Linked to Litigation Proceeds - citybuzz -
Quantum BioPharma (QNTM) Announces Special Dividend in CVRs | QN - GuruFocus
Quantum BioPharma boosts investments in digital assets to $5M - MSN
Quantum BioPharma plans special dividend tied to legal action By Investing.com - Investing.com South Africa
Quantum BioPharma plans special dividend tied to legal action - Investing.com
Quantum Biopharma Plans Special Dividend Linked to Potential Litigation Proceeds - marketscreener.com
Quantum BioPharma Announces Special Dividend Linked to Litigation Proceeds - TipRanks
Quantum BioPharma Ltd. Announces Special Dividend of Contingent Value Rights Linked to Ongoing Litigation Against Banks - Nasdaq
Quantum BioPharma Announces Intention to Declare Special - GlobeNewswire
Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds - GlobeNewswire Inc.
Quantum BioPharma Boosts Digital Asset Holdings To $5 Million With New Bitcoin Purchase - Bitcoin Magazine
Quantum Biopharma Purchases More Bitcoin Bringing Total Investment In Digital Assets To USD $5,000,000 - marketscreener.com
Quantum BioPharma (QNTM) Expands Cryptocurrency Holdings to $5 M - GuruFocus
Quantum BioPharma Expands Cryptocurrency Investment Portfolio - TipRanks
Quantum Biopharma Purchases More Bitcoin (BTC) Bringing the Total Investment in Digital Assets to USD $5,000,000 - GlobeNewswire
Quantum Biopharma Brief: Says Purchased More Bitcoin (BTC) Bringing Total Investment in Digital Assets to US$5 Million - marketscreener.com
Quantum Biopharma buys additional $1 million of Bitcoin, other cryptocurrencies - MSN
Quantum BioPharma clarifies misinformation on stock name, RTO rumors By Investing.com - Investing.com South Africa
Quantum BioPharma Ltd. Clarifies Misinformation Regarding Name Change and RTO Rumors - citybuzz -
Quantum BioPharma Clarifies Name Confusion, Refutes RTO Rumors With Unbuzzd Wellness - Nasdaq
Quantum BioPharma Clarifies It Has Not Changed Its Name | QNTM S - GuruFocus
Quantum BioPharma clarifies misinformation on stock name, RTO rumors - Investing.com
Quantum BioPharma clarifies company has not changed its name - TipRanks
Quantum BioPharma (QNTM) Clarifies Company Name and Transaction Rumors | QNTM Stock News - GuruFocus
Quantum BioPharma Addresses Misinformation and Financial Agreements - TipRanks
Quantum BioPharma Clarifies It Has Not Changed Its Name | QNTM Stock News - GuruFocus
Quantum BioPharma Addresses Misinformation Regarding Unbuzzd Wellness and Clarifies Stock Trading Platform Errors - Nasdaq
Quantum BioPharma Clarifies It Has Not Changed Its Name - GlobeNewswire
Quantum BioPharma Sets Record Straight: No Name Change, Reveals Major Unbuzzd Wellness Stake - Stock Titan
iNGENū CRO Partners with Quantum BioPharma to Launch - GlobeNewswire
Quantum BioPharma settles disputes with former CEO By Investing.com - Investing.com South Africa
Quantum BioPharma Resolves Legal Dispute with Former CEO, Secures $2.35 Million Settlement - citybuzz -
What's Going On With Quantum Biopharma Stock Today? - Benzinga
Quantum BioPharma (QNTM) Settles Disputes with Former CEO | QNTM Stock News - GuruFocus
Quantum BioPharma Settles Legal Dispute with Former CEO, Receives $2.35 Million - TipRanks
Quantum BioPharma settles disputes with former CEO - Investing.com
Quantum Biopharma Brief: Says Received US$2.35 Million From a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari - marketscreener.com
Quantum BioPharma Receives $2.35 Million USD from a - GlobeNewswire
Quantum BioPharma Ends 4-Year Legal Battle with $2.35M Settlement Payment from Ex-CEO - Stock Titan
Quantum BioPharma appoints MNP for IPO readiness audits By Investing.com - Investing.com South Africa
Unbuzzd Wellness Prepares for Potential IPO with New Auditor Appointment - citybuzz -
Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit - GuruFocus
Quantum BioPharma (QNTM) Engages New Auditor for Potential IPO | - GuruFocus
Quantum BioPharma (QNTM) Engages New Auditor for Potential IPO | QNTM Stock News - GuruFocus
Quantum BioPharma’s Licensee Unbuzzd Wellness Prepares for IPO with Audit Firm Engagement - TipRanks
Quantum BioPharma announces Unbuzzd Wellness hired audit firm - TipRanks
Quantum BioPharma appoints MNP for IPO readiness audits - Investing.com Australia
Quantum BioPharma Ltd. Announces Unbuzzd Wellness Inc. Hires MNP LLP for PCAOB Audits Ahead of Possible IPO and Company Name Change - Nasdaq
Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc. - GlobeNewswire
Ex-Coca Cola Exec's Hangover Cure Company Unbuzzd Takes Major Step Toward IPO With Top Audit Firm - Stock Titan
Quantum BioPharma Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202 - marketscreener.com
Quantum Group announces subsidiary received approval by HREC in Australia - TipRanks
Quantum BioPharma (QNTM) Gets Green Light for Australian Clinica - GuruFocus
1.11%
1.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):